Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
Nussbaum SR, Carter MJ, Fife CE, DaVanzo J, Haught R, Nusgart M, et al
Full disclaimer 1.AOD-9604 is a 16-amino acid peptide fragment derived from human growth hormone (hGH residues 177-191) with added tyrosine, developed by Metabolic Pharmaceuticals for obesity treatment 2.Proposed mechanism: selective stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis (fat formation) without growth hormone-like effects on IGF-1 or blood glucose 3.Failed Phase 2b clinical trial for obesity (2007)did not demonstrate statistically significant weight loss versus placebo, terminating clinical development for this indication 4.Received FDA "Generally Recognized as Safe" (GRAS) designation in 2023 as a food substance, but this is NOT a drug approval and does not establish efficacy for weight loss 5.Regulatory status: not FDA-approved as a drug, prohibited by WADA, and insufficient evidence for weight loss efficacy
The role of glutathione is to determine the type of melanin that the body will synthesize, as it increases the synthesis of lighter pheomelanin rather than the darker eumelanin
The likely mechanisms include both peptides anti-inflammatory action, improved cerebral blood flow from angiogenesis, direct neuroprotective signaling, and support for nerve growth factor production
US$ 28.68
US$ 22.71
US$ 20.43
US$ 24.28
US$ 21.86
US$ 26.71
US$ 24.85
US$ 27.40
